Epidemic Meningitis Due to Group A Neisseria Meningitidis in the African Meningitis Belt: A Persistent Problem With an Imminent Solution

This article, published in the journal Vaccine, emphasizes Group A Neisseria meningitidis as a health problem in Africa and disccuses the potential for a proactive control strategy for epidemic meningitis with the use of a meningococcal A conjugate vaccine, which has been shown to be safe and immunogenic in Phase 2 trials in Africa. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)

Author(s): LaForce FM, Ravenscroft N, Djingarey M, et al

Published: 2009

  • Visit web page (English)

    (Located at www.ncbi.nlm.nih.gov)

    Citation: LaForce FM, Ravenscroft N, Djingarey M, et al. Epidemic Meningitis Due to Group A Neisseria Meningitidis in the African Meningitis Belt: A Persistent Problem With an Imminent Solution. Vaccine. 2009;27(Suppl. 2):B13-B19.

Resource types: Peer-reviewed journal

Diseases: Meningococcus

Topics: Disease burden and surveillance; Disease/vaccine specific information

Regions: Africa